German Pharmaceuticals & Biotech Potentially Undervalued Companies

Elanco Animal Health

Market Cap: €9.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Neurocrine Biosciences

Market Cap: €14.0b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Merus

Market Cap: €5.1b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Syndax Pharmaceuticals

Market Cap: €1.3b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

BioNTech

Market Cap: €23.9b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Novavax

Market Cap: €1.1b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Jaguar Health

Market Cap: €11.7m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

Egetis Therapeutics

Market Cap: €1.9b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

argenx

Market Cap: €38.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Orion Oyj

Market Cap: €9.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

SKAN Group

Market Cap: €1.3b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Sumitomo Pharma

Market Cap: €642.8b

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Phibro Animal Health

Market Cap: €1.6b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Orion Oyj

Market Cap: €9.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Gubra

Market Cap: €6.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

Johnson & Johnson

Market Cap: €425.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Grifols

Market Cap: €7.2b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Neuren Pharmaceuticals

Market Cap: €2.5b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Cannabist Company Holdings

Market Cap: €58.7m

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.

Aelis Farma

Market Cap: €18.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Bavarian Nordic

Market Cap: €18.1b

Develops, manufactures, and supplies life-saving vaccines.

Astellas Pharma

Market Cap: €3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Atara Biotherapeutics

Market Cap: €80.8m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Bonesupport Holding

Market Cap: €19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Eledon Pharmaceuticals

Market Cap: €141.9m

Operates as a clinical stage biotechnology company.

Rezolute

Market Cap: €671.6m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Medigene

Market Cap: €988.5k

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

CSPC Pharmaceutical Group

Market Cap: €114.4b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Mesoblast

Market Cap: €2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Aton

Market Cap: €5.9m

Operates as a bioscience company in France.

High Tide

Market Cap: €446.0m

Engages in the cannabis retail business in Canada.

Zevra Therapeutics

Market Cap: €407.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Achieve Life Sciences

Market Cap: €157.4m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

WuXi Biologics (Cayman)

Market Cap: €159.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Soleno Therapeutics

Market Cap: €2.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Sino Biopharmaceutical

Market Cap: €147.9b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.